Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Immutep.
RELATED STOCKHEAD STORIES
News
Market highlights and 4 ASX small caps to watch on Thursday
Health & Biotech
Imugene gains 10pc on cancer vaccine progress; 3 other biotechs getting patents
News
Market highlights and 5 ASX small caps to watch on Wednesday
Experts
ScoPo’s powerplays: His Mach7 pick paid off – will Impedimed rise as well?
News
Last Rounds: Small caps finally get some love, rise 1.2%
Health & Biotech
Immutep shares soar after Bristol Myers Squibb study confirms LAG-3 potency
Health & Biotech
Immutep closes at 3-week high after Merck collaboration extended
News
Market highlights and 5 ASX small caps to watch on Tuesday
News
Last Orders: Small caps gain but tech, BNPL selloff continues
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
Health & Biotech
Immutep Covid-19 trial moves forward in Czech Republic
News
Last Orders: Market dips, but still best week for small caps since early November
Health & Biotech
Imugene, Immutep both complete recruitment for cancer treatment studies
Health & Biotech
Immutep shares gain after company granted US patent, BlackRock ups stake
News
Weekly ASX small cap wrap: Who are the cup winners and wooden spoon recipients?
News
10 at 10: These ASX stocks have surprised their shareholders this morning
News
